Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience
- PMID: 19571170
- DOI: 10.1177/0148607109332773
Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience
Abstract
Parenteral nutrition-associated liver disease (PNALD) is the most prevalent and most severe complication of long-term parenteral nutrition. Its underlying pathophysiology, however, largely remains to be elucidated. The currently approved parenteral lipid emulsions in the United States contain safflower or soybean oils, both rich in omega-6 polyunsaturated fatty acids (PUFAs). Mounting evidence indicates that the omega-6 PUFAs originating from plant oils in these lipid emulsions may play a role in the onset of liver injury. Fish oil-based lipid emulsions, in contrast, are primarily composed of omega-3 PUFAs, thus providing a promising alternative. The authors review the literature on the role of lipid emulsions in the onset of PNALD and discuss prevention and treatment strategies using a fish oil-based lipid emulsion. They conclude that a fish oil-based emulsion is hepatoprotective in a murine model of PNALD, and it appears to be safe and efficacious for the treatment of this type of liver disease in children. A prospective randomized trial that is currently under way at the authors' institution will objectively determine the place of fish oil monotherapy in the prevention of PNALD.
Similar articles
-
Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease.Arch Surg. 2010 Jun;145(6):547-51. doi: 10.1001/archsurg.2010.80. Arch Surg. 2010. PMID: 20566974 Review.
-
Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.Curr Opin Organ Transplant. 2010 Jun;15(3):334-40. doi: 10.1097/mot.0b013e3283394879. Curr Opin Organ Transplant. 2010. PMID: 20503524 Review.
-
Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults.Clin Nutr. 2012 Apr;31(2):217-23. doi: 10.1016/j.clnu.2011.10.001. Epub 2011 Oct 27. Clin Nutr. 2012. PMID: 22035955
-
Prevention of parenteral nutrition-associated liver disease: lipid minimization.Curr Opin Organ Transplant. 2010 Jun;15(3):330-3. doi: 10.1097/MOT.0b013e328338c2da. Curr Opin Organ Transplant. 2010. PMID: 20386446 Review.
-
Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease.Prostaglandins Leukot Essent Fatty Acids. 2013 Sep;89(4):153-8. doi: 10.1016/j.plefa.2013.02.008. Epub 2013 Apr 18. Prostaglandins Leukot Essent Fatty Acids. 2013. PMID: 23602846 Review.
Cited by
-
Multi-omic profiles of hepatic metabolism in TPN-fed preterm pigs administered new generation lipid emulsions.J Lipid Res. 2016 Sep;57(9):1696-711. doi: 10.1194/jlr.M069526. Epub 2016 Jul 29. J Lipid Res. 2016. PMID: 27474222 Free PMC article.
-
Biochemical Parameters in Extremely Preterm Infants Receiving Mixed Lipid Emulsions.J Pediatr Pharmacol Ther. 2021;26(8):841-849. doi: 10.5863/1551-6776-26.8.841. Epub 2021 Nov 10. J Pediatr Pharmacol Ther. 2021. PMID: 34790075 Free PMC article.
-
Composition and Functionality of Lipid Emulsions in Parenteral Nutrition: Examining Evidence in Clinical Applications.Front Pharmacol. 2020 Apr 29;11:506. doi: 10.3389/fphar.2020.00506. eCollection 2020. Front Pharmacol. 2020. PMID: 32410990 Free PMC article. Review.
-
New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs.J Lipid Res. 2014 Mar;55(3):466-77. doi: 10.1194/jlr.M044545. Epub 2014 Jan 29. J Lipid Res. 2014. PMID: 24478031 Free PMC article.
-
Lipid emulsions for parenterally fed preterm infants.Cochrane Database Syst Rev. 2019 Jun 4;6(6):CD013163. doi: 10.1002/14651858.CD013163.pub2. Cochrane Database Syst Rev. 2019. PMID: 31158919 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical